Are adverse effects incorporated in economic models? A survey of current practice. - Wikidata - wikimedia - TriplyDB

Are adverse effects incorporated in economic models? A survey of current practice.

Are adverse effects incorporated in economic models? A survey of current practice.

http://www.wikidata.org/entity/Q37768240

about

Economic evaluations of personalized medicine: existing challenges and current developments The "linked evidence approach" to assess medical tests: a critical analysis.

P2860

Q26797183-4214F049-4C1C-4454-B00F-41F742143AA7 Q38114616-88F28EBB-CD2E-46C7-9BA2-62417E06D5D1

P2860

Are adverse effects incorporated in economic models? A survey of current practice.

http://www.wikidata.org/entity/Q37768240

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Are adverse effects incorporated in economic models? A survey of current practice.

@en

Are adverse effects incorporated in economic models? A survey of current practice.

@nl

type

label

Are adverse effects incorporated in economic models? A survey of current practice.

@en

Are adverse effects incorporated in economic models? A survey of current practice.

@nl

prefLabel

Are adverse effects incorporated in economic models? A survey of current practice.

@en

Are adverse effects incorporated in economic models? A survey of current practice.

@nl

P1433

Q37768240-393AB0AC-A904-4F77-A173-4F5941BD34EF

P1476

Q37768240-C7A991B1-06D6-469A-9E17-EAA5D88A1D93

P2093

Q37768240-00A1ACD5-4EF3-4B9A-A566-02EFF37001F2

Q37768240-0EAB2C4F-F182-4C86-8281-341C6CACF192

Q37768240-9697CE02-66D0-4A5F-835C-EFF1AD0C9E2B

Q37768240-973F346B-EFC2-4FD8-96D0-B2E9D9D222A1

Q37768240-D9A71B06-2107-46A4-9DFE-4EA6B13C5303

Q37768240-DDDBF600-928A-430C-83D6-DBBC26863253

P2860

Q37768240-0D413291-1146-4A99-A9E2-93F9A0BB937C

Q37768240-226C79D7-9E26-456D-BCB1-9EE2A7920411

Q37768240-361CF65E-A824-4E4F-BFCC-A2A7F7907FE8

Q37768240-3BCEEAFF-F3EC-4EA9-896D-ED995CEEAC96

Q37768240-46245489-99B1-42A2-BDAA-E866576B2F21

Q37768240-565808AD-04E7-4683-9D6B-AEF54D8D3BE1

Q37768240-59727D75-E5A1-4DDB-9FFE-5B4C045A6DDC

Q37768240-668A2E34-F06A-42E3-AEA4-E6723B4E4879

Q37768240-686CE3E9-CAEF-49AA-82E5-18251E1155BD

Q37768240-8842DADC-0B9D-493B-9071-1E6FC1B968D6

P304

Q37768240-6423B165-0488-452F-8C35-FC131876B6C1

P31

Q37768240-E865C36B-2CF3-4A9E-B968-0EF9775A2E13

P356

Q37768240-F006EBC2-64DE-4EF7-8024-1E8D5F41EC1D

P433

Q37768240-D3A0E33C-D09E-4A81-9F7E-83B328FC5CB0

P478

Q37768240-9216ACBE-BCCC-4C58-B73E-C683EC3A4E30

P577

Q37768240-C3F6BD6E-757C-46C8-93DB-A27D4436CB20

P698

Q37768240-B4ABC5FB-E096-40E7-B1DD-42EF21891383

P356

S0266462310000371

P1433

International Journal of Technology Assessment in Health Care

P1476

Are adverse effects incorporated in economic models? A survey of current practice.

@en

P2093

Catriona McDaid

http://www.w3.org/2001/XMLSchema#string

Christian Stock

http://www.w3.org/2001/XMLSchema#string

Dawn Craig

http://www.w3.org/2001/XMLSchema#string

Nerys Woolacott

http://www.w3.org/2001/XMLSchema#string

Steven Duffy

http://www.w3.org/2001/XMLSchema#string

Tiago Fonseca

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents

Reporting of adverse events in systematic reviews can be improved: survey results.

Assessment of therapeutic safety in systematic reviews: literature review.

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation.

Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997.

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

P304

323-329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0266462310000371

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20584362

http://www.w3.org/2001/XMLSchema#string